Proteasome inhibitor does not enhance MPTP neurotoxicity in mice

Cellular and Molecular Neurobiology

Volumn 28, Issue 7, 2008, Pages 971-979

  Kadoguchi, Naoto ^a   Umeda, Masahiro ^a   Kato, Hiroyuki ^b   Araki, Tsutomu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Dopamine system; Mice; Parkinson's disease; Proteasome; Western blot analysis

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CARBOBENZOXY LEVO GAMMA TERT BUTYL LEVO GLUTAMYL LEVO ALANYL LEVO LEUCINAL; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEASOME INHIBITOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; DOPAMINE; DRUG SYNERGISM; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROTOXINS; OLIGOPEPTIDES; PARKINSONIAN DISORDERS; PROTEASOME ENDOPEPTIDASE COMPLEX; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS;

EID: 55349104115     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-008-9271-4     Document Type: Article

References (40)

1. T Araki T Kumagai K Tanaka M Matsubara H Kato Y Itoyama Y Imai 2001 Neuroprotective effect of riluzole in MPTP-treated mice Brain Res 918 176 181
2. J Bove C Zhou V Jackson-Lewis J Taylor Y Chu HJ Rideout DC Wu JH Kordower L Petrucelli S Przedbroski 2006 Proteasome inhibition and Parkinson's disease modeling Ann Neurol 60 260 264
3. H Braak K Del Tredici U Rub RA de Vos EN Jansen Steur E Braak 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211
4. RS Burns CC Chiueh SP Markey MH Ebert DM Jacobowitz IJ Kopin 1983 A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Proc Natl Acad Sci USA 80 4546 4550
5. I Camacho-Arroyo O Villamar-Cruz A Gonzalez-Arenas C Guerra-Araiza 2002 Participation of the 26S proteasome in the regulation of progesterone concentrations in the rat brain Neuroendocrinology 76 267 271
6. T Cross 1981 Aquatic actinomycetes: a critical survey of the occurrence, growth and role of actinomycetes in aquatic habitats J Appl Bacteriol 50 397 423
7. W Dauer S Przedborski 2003 Parkinson's disease: mechanisms and models Neuron 39 889 909
8. R Dringen JM Gutterer J Hirrlinger 2000 Gultathione metabolism in brain. Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species Eur J Biochem 267 4912 4916
9. JC Ensign P Normand JP Burden CA Yallop 1993 Physiology of some actinomycete genera Res Microbiol 144 657 660
10. G Fenteany SL Schreiber 1998 Latacystin, proteasome function, and cell fate J Biol Chem 273 8545 8548
11. F Fornai P Lenzi M Gesi M Ferrucci G Lazzeri CL Busceti R Ruffoli P Soldani S Ruggieri MG Alessandri A Paparelli 2003 Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J Neurosci 23 8955 8966
12. F Gallo MC Morale V Spaima-Purrello C Tirolo N Testa Z Farinella R Avola A Beaudet B Marchetti 2000 Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture Synapse 36 233 253
13. RE Heikkila A Hess RC Duvoisin 1984 Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyidine in mice Science 224 1451 1453
14. SJ Hirst B Ferger 2008 Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice Synapse 62 85 90
15. NR Jana P Dikshit A Goswami N Nukina 2004 Inhibition of poteasomal function by curcumin induces apoptosis through mitochondrial pathway J Biol Chem 279 11680 11685
16. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 S26 S38
17. A Kazi DA Urbizu DJ Kuhn AL Acebo ER Jackson GP Greenfelder NB Kumar QP Dou 2003 A natural musaceas plant extract inhibits proteasome activity and induces apotosis selectively in human tumor and transformed, but not normal and non-transformed, cells Int J Mol Med 12 879 887
18. AF Kisselev AL Goldberg 2001 Proteasome inhibitiors: from research tools to drug candidates Chem Biol 8 739 758
19. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 605 608
20. Y Koguchi J Kohno M Nishio K Takahashi T Okuda T Ohnuki S Komatsubara 2000 TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities J Antibiot 53 105 109
21. JH Kordower NM Kanaan Y Chu RS Babu J Stansell BT Terpstra CE Sortwell K Strece-Collier TJ Collier 2006 Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys Ann Neurol 60 264 268
22. R Kurosaki Y Muramatsu H Kato Y Watanabe Y Imai Y Itoyama T Araki 2005 Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice Eur Neuropsychopharmacol 15 57 67
23. JW Langston P Ballard JW Terud I Irwin 1983 Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980
24. KS McNaught R Belizaire O Isacson P Jenner CW Olanow 2003 Altered proteasomal function in sporadic Parkinson's disease Exp Neurol 179 38 46
25. KS McNaught DP Perl AL Brownell CW Olanow 2004 Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease Ann Neurol 56 149 162
26. H Miwa T Kubo A Suzuki K Nishi T Kondo 2005 Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition Neurosci Lett 380 93 98
27. MC Morale PA Serra F L'episcopo C Tirolo S Caniglia N Testa F Gennuso G Giaquinta G Rocchitta MS Desole E Miele B Marchetti 2006 Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration Neuroscience 138 869 878
28. Y Muramatsu R Kurosaki H Watanabe M Michimata M Matsubara Y Imai T Araki 2003 Expression of S100 protein is related to neuronal damage in MPTP-treated mice Glia 42 307 313
29. S Nam DM Smith QP Dou 2001 Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo J Biol Chem 276 13322 13330
30. H Nawashiro M Brenner S Fukui K Shimada JM Hallenbeck 2000 High susceptibility to cerebral ischemia in GFAP-null mice J Cereb Blood Flow Metab 20 1040 1044
31. CW Olanov AH Schapira Y Agid 2003 Neuroprotection of Parkinson's disease: Prospects and promises Ann Neurol 53 Suppl 3 S1 S2
32. L Petrucelli TM Dawson 2004 Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system Ann Med 36 315 320
33. JB Phillips AJ Williams J Adams PJ Elliott FC Tortella 2000 Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in rat model of focal cerebral ischemia Stroke 31 1686 1693
34. A Priyadarshi SA Khuder EA Schaub SS Priyadarshi 2001 Environmental risk factors and Parkinson's disease: a metaanalysis Environ Res 86 122 127
35. AH Schapira MW Cletter JR Muddle JM Workman JM Cooper RH King 2006 Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons Ann Neurol 60 253 255
36. NY Sherman AL Goldberg 2001 Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases Neuron 29 15 32
37. N Sin KB Kim M Elofsson L Meng H Auth BH Kwok CM Crews 1999 Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology Bioorg Med Chem Lett 9 2283 2288
38. K van Leyen A Siddiq RR Ratan EH Lo 2005 Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity J Neurochem 92 824 830
39. N Yamamoto H Sawada Y Izumi T Kume H Katsuki S Shimohama A Akaike 2007 Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress J Biol Chem 282 4364 4372
40. Y Zhang J Gao KK Chung H Huang VL Dawson TM Dawson 2000 Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proc Natl Acad Sci USA 97 13354 13359